60
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Seroprevalence of HIV, HSV-2, and Treponema pallidum in the Kosovarian population

, , , , , , , , , , & show all
Pages 608-613 | Received 24 Feb 2009, Published online: 13 Aug 2009

References

  • EuroHIV. HIV/AIDS Surveillance in Europe. End-year report 2005. Saint-Maurice: Institut de veille sanitaire, 2006 No. 73. Available from: http://www.eurohiv.org/reports/report_73/pdf/report_eurohiv_73.pdf, , [accessed 11 Mar 2008].
  • UNAIDS. Serbia and Montenegro. Country situation analysis. Available from: www.unaids.org/en/Regions_Countries/Countries/serbia_and_montenegro.asp, , [accessed 11 Mar 2008].
  • Dordevi H. Serological response to herpes simplex virus type 1 and 2 infection among women of reproductive age. Med Pregl 2006; 59: 591–7
  • Wald A, Langenberg AGM, Link K, Izu AE, Ashley R, Warren T, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 24: 3100–6
  • Hollier, L, Wendel, G. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst Rev 2008;1:CD004946.
  • Quaglio G, Ramadani N, Pattaro C, Cami A, Dentico P, Volpe A, et al. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol 2008; 80: 833–40
  • UNMIK. Social Affairs-HIV/AIDS. Time to face the truth. Available from: http://www.unmikonline.org/pub/focuskos/dec02/focusksocaffair1.htm, , [accessed 11 Mar 2008].
  • World Bank. 2005. Kosovo Poverty Assessment. Promoting opportunity, security, and participation for all. Poverty reduction and economic management unit. Europe and Central Asia Region. Report n. 32378-XK. Available from: http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2005/07/13/000012009_20050713091826/Rendered/PDF/323780rev.pdf, , [accessed 11 Mar 2008].
  • Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3–17
  • Suligoi B, Cusan M, Santopadre P, Palù G, Catania S, Girelli G, et al. HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum. Sex Transm Infect 2000; 76: 213–4
  • Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, François G, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004; 80: 185–91
  • Dordevi H. Serological response to herpes simplex virus type 1 and 2 infection among women of reproductive age. Med Pregl 2006; 59: 591–7
  • Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296: 964–73
  • Wutzler P, Doerr HW, Färber I, Eichhorn U, Helbig B, Sauerbrei A, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations: relevance for the incidence of genital herpes. J Med Virol 2000; 61: 201–7
  • Gaytant MA, Steegers EA, van Laere M, Semmekrot BA, Groen J, Weel JF, et al. Seroprevalences of herpes simplex virus type 1 and type 2 among pregnant women in the Netherlands. Sex Transm Dis 2002; 29: 710–4
  • Kamali A, Nunn AJ, Mulder DW, van Dyck E, Dobbins JG, Whitworth JA. Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Infect 1999; 75: 98–102
  • Mbizvo EM, Msuya Sia E, Stray-Pedersen B, Chirenje MZ, Munjoma M, Hussain A. Association of herpes simplex virus type 2 with the human immunodeficiency virus among urban women in Zimbabwe. Int J STD AIDS 2002; 13: 343–8
  • Kasubi MJ, Nilsen A, Marsden HS, Bergström T, Langeland N, Haarr L. Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania. J Clin Microbiol 2006; 44: 2801–7
  • van Dyck E, Buvé A, Weiss HA, Glynn JR, Brown DW, de Deken B, et al. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol 2004; 42: 2961–5
  • Ramos S, Lukefahr JL, Morrow RA, Stanberry LR, Rosenthal SL. Prevalence of herpes simplex virus types 1 and 2 among children and adolescents attending a sexual abuse clinic. Pediatr Infect Dis J 2006; 25: 902–5
  • Uusküla A, Nygard-Kibur M, Cowan FM, Mayaud P, French RS, Robinson JN, et al. The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia. Scand J Infect Dis 2004; 36: 727–32
  • Brisson, AE. HIV/AIDS. Time to face the truth. Available from: http://www.unmikonline.org/pub/focuskos/dec02/focuskoscaffair1.htm, , [accessed 11 Mar 2008].
  • Council of Europe. Report on the collection, testing and use of blood and blood products in Europe in 2003. Available from: http://www.coe.int/t/dg3/health/Source/2003reportfinal_en.pdf, , [accessed 11 Mar 2008].
  • Matee MI, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2006; 6: 21
  • Nakashima AK, Rolfs RT, Flock ML, Kilmarx P, Greenspan JR. Epidemiology of syphilis in the United States, 1941–1993. Sex Transm Dis 1996; 23: 16–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.